Segall Bryant & Hamill’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Sell
36,890
-1,119
-3% -$82.3K 0.04% 379
2025
Q4
$2.58M Buy
38,009
+5,235
+16% +$327K 0.03% 398
2025
Q3
$1.87M Sell
32,774
-127
-0.4% -$7.53K 0.02% 444
2025
Q2
$1.82M Buy
+32,901
New +$1.54M 0.03% 448

Other funds holding DBD

Segall Bryant & Hamill's DBD Position: Q1 2026 in Review

Segall Bryant & Hamill reduced its Diebold Nixdorf (DBD) stake by 2.9% in Q1 2026, selling an estimated $82.3K and leaving 36,890 shares worth $2.78M. The position accounts for 0.04% of the portfolio, ranked #379.

Segall Bryant & Hamill first reported a position in DBD in Q2 2025 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Segall Bryant & Hamill held 36,890 shares of Diebold Nixdorf worth $2.78M as of Q1 2026.
  • Segall Bryant & Hamill sold 1,119 Diebold Nixdorf shares in Q1 2026, an estimated $82.3K.
  • Diebold Nixdorf made up 0.04% of Segall Bryant & Hamill's portfolio in Q1 2026, its #379 holding.
  • Segall Bryant & Hamill first reported a position in Diebold Nixdorf in Q2 2025 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.